Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
Phase 2
Terminated
- Conditions
- Glomerulonephritis, IGAKidney DiseasesAcute Renal InsufficiencyRapidly Progressive Glomerulonephritis
- Interventions
- Procedure: Plasma Exchange (PE)
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2021-10-08
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02647255
- Locations
- 🇨🇳
Renal Division, Department of Medicine, Peking University First Hospital, Beijing, Beijing, China
🇨🇳Renal division, Peking University First Hospital, Beijing, Beijing, China
Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications
Phase 4
Completed
- Conditions
- Postoperative Complications
- Interventions
- Drug: Placebo inhalation
- First Posted Date
- 2016-01-01
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 864
- Registration Number
- NCT02644876
- Locations
- 🇨🇳
Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, Beijing, China
Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension
- First Posted Date
- 2015-12-29
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 700
- Registration Number
- NCT02641821
- Locations
- 🇨🇳
Division of Cardiology, Peking University First Hospital, Beijing, China
Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection
Completed
- Conditions
- Hepatitis B
- Interventions
- Other: physicians
- First Posted Date
- 2015-07-30
- Last Posted Date
- 2015-11-06
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 2871
- Registration Number
- NCT02511743
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Prevalence of Chronic Kidney Disease and Its Association With Clinical Outcome in Patients With Coronary Heart Disease
- Conditions
- Chronic Kidney DiseaseCoronary Heart Disease
- First Posted Date
- 2015-07-27
- Last Posted Date
- 2016-06-21
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT02509013
- Locations
- 🇨🇳
Peking University First hospital, Beijing, Beijing, China
Feasibility of Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue for Assessment of Tubal Patency
- Conditions
- Four Dimensional Hysterosalpingo-contrast SonographyTubal Patency
- First Posted Date
- 2015-07-22
- Last Posted Date
- 2015-07-22
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 380
- Registration Number
- NCT02505555
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Effectivity and Safety Study of Trans-artificial-urethral Resection of Female Urethral Caruncle
Not Applicable
- Conditions
- Urethral Caruncle
- Interventions
- Procedure: TAURFUC
- First Posted Date
- 2015-07-03
- Last Posted Date
- 2015-07-03
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT02490228
Chinese Acute Ischemic Stroke Treatment Outcome Registry
- Conditions
- Ischemic Stroke
- Interventions
- Other: treatment following current guideline
- First Posted Date
- 2015-06-12
- Last Posted Date
- 2015-10-23
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT02470624
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, China
Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients
Phase 4
Completed
- Conditions
- Patients Needing Continuous Renal Replacement TherapyCritical Ill Patients
- Interventions
- Device: AN69ST hemofilterDevice: AN69 hemofilter
- First Posted Date
- 2015-02-04
- Last Posted Date
- 2021-05-26
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT02355873
- Locations
- 🇨🇳
Renal division,department of Medcine,Peking University First Hospital, Beijing, Beijing, China
Combination Therapy Prevents the Relapse of RA
Not Applicable
- Conditions
- Recurrence (Disease Attribute)
- Interventions
- First Posted Date
- 2014-12-19
- Last Posted Date
- 2020-06-22
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT02320630
- Locations
- 🇨🇳
Rheumatology and Immunology Department,Peking University First Hospital, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath